PeerView Press Home Page
Before beginning, scroll to review all program information. To proceed, you must click the "Start This Activity" button.

Activity Description & Educational Objectives

This educational activity is based on a recent live symposium addressing the diagnosis and treatment of Morquio A, also known as MPS IVA. Our expert faculty offers up-to-date review of Morquio A assessment and management, with a look at the future, and a discussion of how new evidence will affect daily care, while ensuring that providers understand how to implement best practices in the optimal management of their patients with Morquio A.

Upon completion of this activity, participants should be better able to:

  • Describe the spectrum of clinical presentation and symptom complex of MPS IVA/Morquio A syndrome
  • Establish an accurate diagnosis of MPS IVA based on clinical, radiographic, and laboratory findings according to the currently recommended diagnostic algorithm
  • Discuss the latest clinical trial data on treatments for MPS IVA/Morquio A syndrome, including enzyme replacement therapy (ERT)
  • Integrate the latest therapies into the care plans of patients with MPS IVA

Target Audience

This activity has been designed to meet the educational needs of geneticists and genetic counselors involved in the management of patients with Morquio A.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: May 02, 2014 - May 01, 2015
Time to Complete: 90 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Paul Harmatz, MD
Gastroenterology and Nutrition
Children's Hospital & Research Center Oakland
Oakland, California

Paul Harmatz, MD, has a financial interest/relationship or affiliation in the form of:

Consultant for BioMarin Pharmaceutical Inc.and Shire.

Grant/Research Support from Alexion Pharmaceuticals, Inc./Enobia Pharma Corp.; BioMarin Pharmaceutical Inc.; Genzyme Corporation, a Sanofi company; and Shire.

Speakers Bureau participant with BioMarin Pharmaceutical Inc.

Interviewee

Barbara K. Burton, MD
Genetics, Birth Defects and Metabolism
Ann and Robert H. Lurie Children’s Hospital of Chicago
Chicago, Illinois

Barbara K. Burton, MD, has a financial interest/relationship or affiliation in the form of:

Consultant for BioMarin Pharmaceutical Inc. and Shire.

Grant/Research Support from BioMarin Pharmaceutical Inc.; Genzyme Corporation, a Sanofi company; Shire; Synageva BioPharma; and Ultragenyx Pharmaceutical Inc.

Speakers Bureau participant with Shire and Synageva BioPharma.

Medical Director

Christopher Washburn, PhD
PVI, PeerView Institute for Medical Education

Christopher Washburn, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Sponsorship, Credit & Support

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G5464-14-T.

This CME activity is jointly sponsored by Penn State College of Medicine and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from BioMarin Pharmaceutical Inc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

 

We do not recognize you as a registered member.
Please log in by selecting your specialty below:

I have read the required activity information
Start This Activity